Related by context. All words. (Click for frequent words.) 73 modifiable risk 70 Genetic predisposition 68 Genetic variants 68 thromboembolic disease 67 Singh Manoux 67 IPAH 67 prostate cancer CaP 67 underlying pathophysiology 67 genetic polymorphisms 67 prostate carcinogenesis 67 etiological 67 dyslipidaemia 66 impaired glucose metabolism 66 etiologic 66 metabolic abnormalities 66 lipid abnormalities 66 pharmacologic intervention 66 Vitamin D insufficiency 66 obesity insulin resistance 66 multifactorial 66 impaired cognition 65 abnormal lipids 65 systemic inflammation 65 familial predisposition 65 atherothrombotic 65 APOE genotype 65 metabolic dysfunction 65 lipoprotein metabolism 65 antenatal depression 65 antioxidant supplementation 65 hypovitaminosis D 65 metabolic disturbances 64 gallstone disease 64 hereditary predisposition 64 arterial calcification 64 Socioeconomic status 64 Oxidative damage 64 myocardial ischaemia 64 subclinical atherosclerosis 64 airway hyperresponsiveness 64 comorbid disorders 64 hypertension diabetes mellitus 64 impaired insulin secretion 64 familial clustering 64 plasma lipid 64 cardiovascular disease hypertension 64 dysglycemia 64 predisposing factor 64 atherosclerotic vascular disease 64 DVT PE 64 prognostic indicators 64 cardiac insufficiency 64 androgen deficiency 64 prothrombotic 64 aetiological 64 obesity sedentary lifestyle 64 renal fibrosis 64 breast endometrial 64 causal pathway 64 hyperinsulinemia 64 pathophysiological 64 dyslipidemia hypertension 64 diabetes dyslipidemia 64 diabetic kidney 64 atherothrombotic disease 63 autonomic dysfunction 63 Angiotensin converting enzyme 63 etiologic factors 63 Fatty liver 63 cardiometabolic disorders 63 postoperative AF 63 atherothrombosis 63 G6PD deficiency 63 microvascular disease 63 postoperative pulmonary 63 unfavorable prognostic 63 nongenetic 63 subfertility 63 macrovascular complications 63 vascular dysfunction 63 coronary artery atherosclerosis 63 pulmonary hypertension PH 63 carotid atherosclerosis 63 mtDNA mutations 63 predisposing factors 63 cardiac fibrosis 63 oesophageal adenocarcinoma 63 modifiable lifestyle 62 diabetes mellitus hypertension 62 airway remodeling 62 cardio metabolic 62 elevated triglyceride levels 62 macrovascular disease 62 atherogenic dyslipidemia 62 nonalcoholic steatohepatitis 62 hypoxemia 62 familial hypercholesterolemia 62 metabolic dysregulation 62 coinfection 62 MYH9 62 CVD mortality 62 comorbid depression 62 mitochondrial toxicity 62 thyroid dysfunction 62 multi factorial disease 62 chronic thromboembolic pulmonary 62 pathophysiologic 62 macrovascular events 62 biologic pathways 62 Chronic inflammation 62 carbohydrate metabolism 62 immune dysregulation 62 hemodilution 62 diabetic microvascular complications 62 Aortic stenosis 62 T1DM 62 residual confounding 62 FGFs 62 pleiotropic effects 62 carotid plaques 62 LV dysfunction 62 modifiable cardiovascular 62 cytomegalovirus infection 62 Sociodemographic 62 testicular tumors 62 primary aldosteronism 62 nonadherence 62 antiphospholipid syndrome 62 neonatal morbidity 62 Endothelial dysfunction 62 NAFLD 62 unmeasured factors 62 inflammatory bowel syndrome 62 serum parathyroid hormone 62 multisystem disease 62 hyperhomocysteinemia 62 venous thromboembolic disease 62 bicuspid aortic valves 62 alexithymia 62 abnormal lipid 62 thrombophilia 62 comorbid anxiety 62 hypothalamic pituitary adrenal axis 62 idiopathic pulmonary 62 gestational diabetes mellitus 62 hypercholesterolemia 62 paraneoplastic 62 epigenetic changes 62 mitochondrial mutations 62 disease NAFLD 62 etiological factors 62 prognostic indicator 62 circulating estrogens 62 co morbidities 61 Oxidative stress 61 microvascular dysfunction 61 hypercholesterolaemia 61 perioperative complications 61 chorioamnionitis 61 sonographic diagnosis 61 abdominal adiposity 61 SE alleles 61 atherosclerotic cardiovascular 61 serum leptin 61 subclinical hypothyroidism 61 morbidity mortality 61 aetiology 61 unmeasured confounders 61 thromboembolism 61 Pulmonary hypertension 61 inflammatory rheumatic 61 MYH9 gene 61 neuroinflammation 61 cardiometabolic risk 61 renal scarring 61 RIP1 61 Hypertriglyceridemia 61 pharmacological therapies 61 neurocognitive deficits 61 SSc 61 pathophysiological mechanisms 61 Heavy menstrual bleeding 61 dietary antioxidants 61 metabolic abnormality 61 endophenotypes 61 metabolic syndromes 61 myeloproliferative neoplasms 61 Heritability 61 endotoxemia 61 underdiagnosis 61 AUDs 61 perioperative morbidity 61 antipsychotic induced 61 multivariate adjustment 61 Prehypertension 61 confounder 61 coagulation abnormalities 61 atherogenesis 61 shorter telomere length 61 inversely associated 61 Ischemic heart 61 psychiatric comorbidity 61 Nonalcoholic fatty liver 61 chlamydial infection 61 intermittent hypoxia 61 Subgroup analyzes 61 familial aggregation 61 periodontal infections 61 Genetic variations 61 Magnesium deficiency 61 multi factorial 61 valvular heart disease 61 secondary amenorrhea 61 inherited predisposition 61 colorectal adenoma 61 carotid bruit 61 insulin resistance 61 periodontal diseases 61 arrhythmogenic 61 HeFH 61 polyp recurrence 61 elevated CRP 61 stratifying patients 61 cardiac dysfunction 61 comorbidity 61 leptin deficiency 61 placenta praevia 61 elevated triglycerides 61 Vitamin D supplementation 61 elevated IOP 61 neurocognitive impairment 61 pathophysiologic mechanisms 61 Hp2 2 61 systolic hypertension 61 postoperative atrial fibrillation 61 vitamin D inadequacy 61 diabetes hyperlipidemia 61 mixed hyperlipidemia 61 neovascularisation 61 Comorbid 61 folate deficiency 61 Secondhand smoke exposure 61 prognostic significance 60 familial pancreatic cancer 60 recurrent miscarriage 60 Genetic variation 60 abnormal glucose tolerance 60 perinatal morbidity 60 pathogenetic 60 gallstone formation 60 arterial thickening 60 ALI ARDS 60 immunomodulation 60 genetic determinants 60 thiopurine 60 myocardial fibrosis 60 gastric lymphoma 60 Pseudomonas aeruginosa infections 60 Homocysteine 60 preserved ejection fraction 60 sociodemographic factors 60 abnormal lipid levels 60 type2 diabetes 60 nonalcoholic fatty liver 60 Cognitive impairment 60 clinicopathological 60 asymptomatic bacteriuria 60 recurrent acute pancreatitis 60 untreated hypothyroidism 60 elevated homocysteine 60 ABCB1 60 behavioral disinhibition 60 cardiometabolic syndrome 60 hyperparathyroidism 60 Thyroid hormone 60 cardio vascular disease 60 lipohypertrophy 60 colorectal carcinogenesis 60 biopsychosocial 60 abnormal glucose metabolism 60 leiomyomas 60 body fatness 60 Uncontrolled hypertension 60 obstructive coronary artery 60 prenatal exposures 60 gene polymorphisms 60 untreated celiac disease 60 thrombo embolic 60 PIGF 60 Prognostic factors 60 genetic loci 60 somatoform disorders 60 maternal morbidity 60 secondary hyperparathyroidism 60 microangiopathy 60 sociodemographic characteristics 60 cystic fibrosis chronic pancreatitis 60 neurodevelopmental outcomes 60 SIADH 60 menstrual irregularity 60 Venous thromboembolism 60 nonalcoholic steatohepatitis NASH 60 alkalosis 60 genetic polymorphism 60 hyperglycaemia 60 SRBD 60 prognostic marker 60 EGFR mutation status 60 tumor histology 60 Subclinical 60 neuronal dysfunction 60 Brain derived neurotrophic 60 Diabetic nephropathy 60 unmeasured confounding 60 estrogen metabolism 60 hyperlipidaemia 60 Erythropoietic therapies may 60 psychosocial stressors 60 gastrointestinal GI bleeding 60 endometrial hyperplasia 60 thyrotropin 60 arteriosclerotic 60 vitamin B# deficiency 60 BMPR2 60 dysfunctional voiding 60 Hashimoto thyroiditis 60 breast cancer metastasis 60 hypercalciuria 60 Hypoglycaemia 60 probiotic supplementation 60 glucose homeostasis 60 chronicity 60 Nonalcoholic Fatty Liver Disease 60 cardiovascular disease 60 AAT deficiency 60 myocardial dysfunction 60 HIV HCV coinfected 60 urolithiasis 60 statins cholesterol lowering 60 neurohormonal 60 Univariate analysis 60 insulin resistance precursor 60 bone metabolism 60 de ath 60 diabetic polyneuropathy 60 phenotypic expression 60 V Leiden 60 insulin resistance syndrome 60 Glucocorticoids 60 atherosclerotic cardiovascular disease 60 HER2 positivity 60 plasma lipids 60 psychosocial variables 60 onset diabetes mellitus 60 androgen excess 60 Heavy snorers 60 obese postmenopausal 60 Zinc deficiency 60 growth hormone secretion 60 Kalantar Zadeh 60 Female Athlete Triad 59 Adequate vitamin D 59 cardiovascular morbidity 59 mucosal inflammation 59 familial adenomatous polyposis 59 CaM kinase II 59 hyperkalemia 59 comorbid conditions 59 thrombotic complications 59 thromboembolic 59 anovulatory infertility 59 atopic sensitization 59 nonpharmacologic 59 lymphocyte activation 59 macroalbuminuria 59 atopic disorders 59 biologic plausibility 59 PLMs 59 epigenetic mechanisms 59 Ascherio 59 Polycystic ovary syndrome PCOS 59 Sleep disturbances 59 HER2 overexpression 59 lipid profiles 59 inflammatory biomarkers 59 nephrolithiasis 59 cartilage degeneration 59 cardioprotective effect 59 chromium supplementation 59 hormone imbalances 59 premenstrual syndrome PMS 59 Calcium intake 59 Sleep disordered breathing 59 FGFR2 59 arterial inflammation 59 diabetes mellitus DM 59 monoclonal gammopathy 59 TCF#L# gene 59 amenorrhoea 59 p# activation 59 Diabetes mellitus 59 Sarcopenia 59 embolic stroke 59 myocardial ischemia 59 monogenic 59 Atopic dermatitis 59 myopathies 59 primary ovarian insufficiency 59 nonfasting triglyceride levels 59 immunopathology 59 endogenous hormones 59 polycystic ovary 59 lichen planus 59 extramedullary 59 cardiac hypertrophy 59 nonbacterial prostatitis 59 Familial hypercholesterolemia 59 gastric cardia 59 cirrhosis liver failure 59 Maternal obesity 59 Iron deficiency anemia 59 Thiazolidinediones 59 reproductive tract infections 59 channelopathies 59 distal colon cancer 59 arterial hypertension 59 CVD cardiovascular disease 59 elevated fasting glucose 59 cerebrovascular diseases 59 Insulin resistance 59 cardiomyopathies 59 erythropoietic 59 airway responsiveness 59 KIF6 carriers 59 loop diuretics 59 COX2 59 spontaneous preterm birth 59 developmental neurotoxicity 59 cholestasis 59 Proteinuria 59 airway reactivity 59 abnormal vaginal bleeding 59 subclinical cardiovascular disease 59 podocyte 59 postmenopausal hormone replacement 59 idiopathic intracranial hypertension 59 carbohydrate intolerance 59 progressive dyspnea 59 primary hyperparathyroidism 59 gastro oesophageal reflux 59 LRP5 59 recurrent venous thromboembolism 59 hemorrhagic complications 59 atherosclerotic coronary 59 H pylori 59 MetS 59 Endometrial cancer 59 mammographic density 59 bacterial prostatitis 59 serum PTH 59 hormone aldosterone 59 Psychosocial interventions 59 CP CPPS 59 bronchial hyperresponsiveness 59 asplenia 59 lupus scleroderma 59 noncardiovascular mortality 59 intracerebral haemorrhage 59 chronic prostatitis 59 underlying molecular mechanisms 59 Multivariate analyzes 59 neurocognitive dysfunction 59 Leydig cell 59 variceal bleeding 59 bile acid metabolism 59 elevated LDL cholesterol 59 valvular heart 59 neurocognitive functioning 59 CYP#D# genotype 59 prognostic markers 59 atherosclerotic disease 59 transferrin saturation 59 comorbid psychiatric 59 polymorphic ventricular tachycardia 59 HPA axis 59 Vitamin B# deficiency 59 acetabular dysplasia 59 coinfected patients 59 vascular inflammation 59 chronic relapsing 59 MGUS 59 testicular germ cell 59 subclinical disease 59 cardioprotective effects 59 plasma kallikrein 59 Non Alcoholic Fatty 59 WNK1 59 cholinergic tone 59 Fibroblast growth 58 CYP #A# 58 carotid plaque 58 lowering blood glucose 58 post thrombotic syndrome 58 contrast induced nephropathy 58 beta carotene supplementation 58 pressure natriuresis 58 extrapyramidal symptoms 58 neurotrophic 58 fatty acid oxidation 58 Bacterial vaginosis 58 gastric carcinoma 58 alcoholic fatty liver 58 cholesterol metabolism 58 gonococcal 58 postmenopausal breast cancer 58 Chronic pancreatitis 58 pharmacologic treatments 58 predisposing 58 silent myocardial ischemia 58 fibrotic disease 58 Excessive daytime sleepiness 58 meta analytic review 58 Observational studies 58 p# mutations 58 hypogonadotropic hypogonadism 58 excitotoxic 58 Exacerbations 58 Trichomonas vaginalis 58 NOD2 58 thyroid deficiency 58 Premature Ovarian Failure 58 pharmacological interventions 58 molecular determinants 58 vascular endothelial 58 neurodevelopmental outcome 58 granulomatous 58 impaired endothelial 58 pretransplant 58 Diabetic neuropathy 58 persistent pulmonary hypertension 58 lung fibrosis 58 dyslipidemias 58 congenital adrenal hyperplasia CAH 58 atopic disease 58 distal embolization 58 postmenopausal hormone 58 TCF#L# 58 hepatic cirrhosis 58 chronic periodontitis 58 lipid levels 58 dentinal hypersensitivity 58 echocardiographic parameters 58 DNA methylation patterns 58 psychosocial functioning 58 histological subtype 58 Anorexia nervosa 58 Clusterin 58 allostatic load 58 aldosterone hormone 58 inducible nitric oxide synthase 58 Generalized anxiety disorder 58 hypothalamus pituitary 58 chronic obstructive airway 58 artery stenosis 58 causal pathways 58 thromboxane A2 58 clinico pathological 58 hypertension hypercholesterolemia 58 rhinovirus infection 58 comorbid illnesses 58 CagA 58 covariate 58 Stress urinary incontinence 58 susceptibility loci 58 thrombotic events 58 placental malaria 58 psychiatric morbidity 58 angina myocardial infarction 58 multifactorial disease 58 heterozygous familial 58 folate metabolism 58 hepatic fibrosis 58 premorbid 58 cardiovascular disease osteoporosis 58 morbidity 58 carotid IMT 58 fibroids endometriosis 58 postoperative delirium 58 gene polymorphism 58 alcoholic liver cirrhosis 58 Periodontitis 58 histologic subtype 58 obstructive coronary 58 undiagnosed celiac disease 58 somatic symptoms 58 melanocortin receptor 58 postpartum hemorrhage 58 improves insulin sensitivity 58 rheumatic disease 58 nonfasting triglycerides 58 maintaining cardiorespiratory fitness 58 ADAMTS# 58 PAOD 58 genetic variants associated 58 pathophysiological processes 58 susceptibility gene 58 hormonal abnormalities 58 PB1 F2 58 intracranial hypertension 58 lipid metabolism 58 central corneal thickness 58 IUGR 58 EBV infection 58 Shlipak 58 atherosclerotic progression 58 nitric oxide synthase 58 molecular mechanisms underlying 58 Epstein Barr Virus EBV 58 LQTS 58 pathogenesis 58 coagulopathy 58 haematopoietic 58 etiology 58 severe hyperbilirubinemia 58 Premature menopause 58 mortality morbidity 58 intact parathyroid hormone 58 nodal metastasis 58 polygenic 58 nephron 58 HRQOL 58 aromatase inhibitors AIs 58 ventricular remodeling 58 HbF 58 bronchopulmonary dysplasia 58 Apolipoprotein E 58 endothelial dysfunction 58 chronic prostatitis chronic 58 HER2 expression 58 hypercoagulable 58 PCOD 58 intestinal permeability 58 Thromboembolic 58 autoimmune thyroid 58 hyperphenylalaninemia HPA due 58 metabolic acidosis 58 dietary choline 58 Nicotine dependence 58 PON1 58 cerebral infarction 58 Hypertensive 58 platelet activation 58 immunomodulatory effects 58 neuro endocrine 58 H. pylori infection 58 viral etiology 58 narcolepsy cataplexy 58 serum estradiol 58 cerebral microbleeds 58 Atopic 58 persistency mortality 58 idiopathic pulmonary arterial hypertension 58 Jean Pierre Després 58 natriuresis 58 infantile hemangioma 58 atrial tachyarrhythmias 58 serum vitamin D 58 endothelial activation 58 obstetric complications 58 STAT4 58 Rh incompatibility 58 HBV infection 58 Dysregulation 58 Catheter Associated 58 ADPKD 58 Statin therapy 58 IGFBP2 58 chlamydial 58 testosterone supplementation 58 depressive symptomatology 58 Fecal incontinence 58 precursor lesions 58 abdominally obese 58 congential 58 Chronic constipation 58 serum phosphate 58 dysrhythmias 58 myeloproliferative diseases 58 Dental caries 58 Physical inactivity 58 chronic rheumatic 58 arterial stiffening 58 Abdominal fat 58 carotid stenosis 58 underactive thyroid gland 58 hepatitis B infection 58 gastric adenocarcinoma 58 chromosomal instability 58 metabolic parameters 58 hemoglobinopathies 58 neuritic 58 neuropsychological deficits 58 hyperinsulinism 58 pharmacological approaches 58 tumor subtypes 58 biochemical abnormalities 58 pathologic fractures 58 NSAID induced GI 58 hepatocellular 58 fetal malformations 58 cardiac conduction 58 unhealthy dietary habits 57 AT1R 57 neurologic complications 57 overt hypothyroidism 57 lipid parameters 57 synovial cells 57 Beta thalassemia 57 transfusion syndrome 57 serotonin deficiency 57 OSAHS 57 upper airway obstruction 57 Chlamydia pneumoniae 57 antithrombotic therapy 57 postoperative morbidity 57 Severe Primary IGFD 57 MTHFR 57 neuroinflammatory 57 TGFBR1 * 6A 57 histone deacetylases 57 dietary calcium intake 57 sociodemographic variables 57 antiphospholipid antibodies 57 Posttraumatic stress disorder 57 anticoagulants blood thinners 57 thyrotropin levels 57 euthymic patients 57 poststroke depression 57 neurogenic 57 bronchopulmonary dysplasia BPD 57 thyroid hormone levels 57 spontaneous preterm delivery 57 autosomal recessive genetic 57 fetal chromosomal 57 NQO1 57 poorer prognosis 57 upper gastrointestinal bleeding 57 left ventricular hypertrophy 57 dopamine receptor gene 57 induced cardiomyopathy 57 coronary atherosclerosis 57 FGFR2 gene 57 mutant huntingtin protein 57 intracranial stenosis 57 chromosomal rearrangement 57 susceptibility genes 57 metabolic syndrome MetS 57 immunological mechanisms 57 physiologic mechanisms 57 proinflammatory 57 cardioembolic stroke 57 PTPN# 57 Intussusception 57 Logistic regression analysis 57 adenomatous polyps 57 adrenal function 57 dietary folate 57 cardio metabolic diseases 57 neurological abnormalities 57 Testosterone deficiency 57 central adiposity 57 hyperstimulation 57 plasma lipoprotein 57 dyslipidemia 57 Pre eclampsia 57 Calorie restriction 57 GH deficiency 57 serum BDNF 57 Helicobacter pylori infection 57 ERK signaling 57 dermatologic reactions 57 gastric atrophy 57 angina chest 57 vitamin D insufficiency 57 Neuroticism 57 multivariate analyzes 57 APOE e4 57 TNF blocker therapy 57 HNSCC 57 pharmacological intervention 57 vasomotor 57 Chlamydia infection 57 nonischemic 57 subclinical hyperthyroidism 57 fetal microchimerism 57 Myocardial infarction 57 coinfections 57 intrapartum 57 pulmonary hypoplasia 57 Candidiasis 57 Ovary removal 57 NAGS deficiency 57 pathogenetic mechanisms 57 preterm neonates 57 hereditary hemochromatosis 57 fructose intake 57 serum albumin 57 Estrogen deficiency 57 node metastases 57 overactive bladder symptoms 57 Jialal 57 cardioprotection 57 atrophic gastritis 57 Coronary artery calcification 57 glycated hemoglobin levels 57 untreated OSA 57 myeloperoxidase 57 VEGF expression 57 SNP rs# [002] 57 glucocorticoid therapy 57 allergic sensitization 57 lupus erythematosus 57 Primary IGFD 57 serum GGT 57 Idiopathic pulmonary fibrosis 57 β blockers 57 remnant lipoproteins 57 polycystic ovary syndrome 57 adiposity 57 oncogenesis 57 polycystic ovarian syndrome PCOS 57 apo B 57 albuminuria 57 left ventricular diastolic 57 estrogen deficiency 57 DHEA supplementation 57 neurocognitive function 57 dietary acrylamide 57 Eisenmenger syndrome 57 folic acid deficiency 57 Hyperphosphatemia 57 fibrotic lung 57 serum lipid levels 57 germline mutations 57 treatment emergent hyperglycemia 57 tryptase 57 parkinsonian symptoms 57 cardiolipin 57 Interstitial cystitis 57 Adjuvant chemotherapy 57 antidiabetic drugs 57 posttransplant 57 methylenetetrahydrofolate reductase 57 Nocturia 57 Neurological disorders 57 hypercoagulability 57 UCP2 57 T2DM 57 Treg cell 57 oncogenic HPV 57 polymicrobial 57 tumor subtype 57 pulmonary emphysema 57 LPS induced 57 SLC#A# [002] 57 elevated hsCRP 57 dominantly inherited 57 K ras mutations 57 pharmacokinetic interactions 57 Prostate enlargement 57 ovarian hormones 57 Sjögren syndrome 57 somatostatin analogs 57 HIVAN 57 estrone 57 antiplatelet medications 57 acute aortic dissection 57 atopic 57 Chemotherapy induced 57 Aldosterone 57 psychiatric comorbidities 57 vascular reactivity 57 adiponectin levels 57 adrenocortical 57 eicosanoids 57 cervicitis 57 interstitial lung abnormalities 57 socioeconomic gradient 57 non ulcer dyspepsia 57 proliferative diabetic retinopathy 57 atherosclerosis 57 cranial irradiation 57 G allele 57 mitochondrial metabolism 57 hepatic steatosis 57 serum lipid 57 Barrett esophagus precancerous 57 GBA mutations 57 mechanistic explanation 57 autosomal dominant disorder 57 autoimmune thyroiditis 57 hypertension 57 endometriosis ovarian cysts 57 Alzheimer pathology 57 endocrinologic 57 proinflammatory cytokine 57 postoperative infections 57 metastatic bone 57 apoE4 57 unstable detrusor muscle 57 chronic obstructive lung 57 atopic asthma 57 growth restriction IUGR 57 ischemic vascular 57 Gastroparesis 57 visceral adiposity 57 cardiovascular comorbidities 57 precancerous cervical 57 Socioeconomic factors 57 Elevated triglycerides 57 dysregulation 57 Melasma 57 premalignant 57 Thyroid disorders 57 socioeconomic deprivation 57 CMV infection 57 vascular constriction 57 subclinical 57 clinically detectable 57 selenium deficiency 57 diabetic retinopathy DR 57 postprandial hyperglycemia 57 bronchoalveolar 57 Comorbidity 57 Chlamydia trachomatis infection 57 multivariable analysis 57 angiographically 57 mGluR5 inhibition 57 cerebral oxygenation 57 virally induced 57 leptin resistance 57 Viral infections 57 atypical antipsychotic medications 57 Hypertrophic cardiomyopathy 57 insulin sensitizing 57 #beta HSD1 57 cryptogenic stroke 57 aortic atherosclerosis 57 diabetes mellitus 57 imatinib resistance 57 cardiovascular mortality 57 androgen hormone 57 eotaxin 57 aortic stiffness 57 Osteopenia 57 occlusive disease 57 BRCA carriers 57 glycogen metabolism 57 intensive statin therapy 57 Postnatal depression 57 adverse perinatal 57 serum calcium 57 creatine supplementation 57 apolipoprotein E4 57 C. trachomatis 57 Von Willebrand disease 57 cirrhotic patients 57 proteoglycan 57 perinatal outcomes 57 molecular abnormalities 57 Von Willebrand 57 prematurity ROP 57 IRF6 57 bacteriuria 57 Vertebral fractures 57 Dr. Chodick 57 thrombocytopenic 57 Dyslipidemia 57 NOMID 56 Genetic susceptibility 56 microcirculatory 56 adiponectin 56 chromosome #p#.# 56 Skeletal muscle 56 polyarticular 56 nontraumatic 56 natriuretic peptides 56 catabolism 56 Nanobacteria 56 periprocedural MI 56 #,# DCB 56 Hypothalamic 56 Sezary syndrome 56 neuropsychiatric disorders 56 de novo mutations 56 glucocorticoid hormones 56 noncardiovascular 56 Hip fracture 56 abdominal obesity